DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
94 hedge funds and large institutions have $14.9M invested in DermTech, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 41 reducing their positions, and 43 closing their positions.
114% more call options, than puts
Call options by funds: $377K | Put options by funds: $176K
26% less funds holding
Funds holding: 127 → 94 (-33)
56% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 41
70% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 43
71% less capital invested
Capital invested by funds: $51M → $14.9M (-$36.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$676K |
| 2 |
GS
Gagnon Securities
New York
|
+$424K |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$416K |
| 4 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
+$344K |
| 5 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
+$289K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$5.6M |
| 2 |
AAMU
AEGON Asset Management (UK)
Edinburgh,
United Kingdom
|
-$2.03M |
| 3 |
Millennium Management
New York
|
-$1.69M |
| 4 |
AIA
Avalon Investment & Advisory
Houston,
Texas
|
-$1.46M |
| 5 |
RI
RTW Investments
New York
|
-$1.06M |
DMTK Hedge Fund Activity: Q4 2022 in Review
94 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q4 2022, worth a combined $14.9M — down 71% from $51M a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of DMTK and 13 opened new positions — a net loss of 30 holders — while 41 trimmed existing stakes and 18 added.
The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $676K. The largest seller was UBS O'Connor, exiting entirely with an estimated $5.6M sold.
- 94 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q4 2022, down from 127 in Q3 2022.
- Funds reported $14.9M of DermTech, Inc. Common Stock stock for Q4 2022, down 71% quarter-over-quarter.
- 13 funds opened new DermTech, Inc. Common Stock positions in Q4 2022 and 43 closed out, a net change of -30 holders.
- The largest DermTech, Inc. Common Stock buyer in Q4 2022 was D.E. Shaw & Co, an estimated $676K added.
- The largest DermTech, Inc. Common Stock seller in Q4 2022 was UBS O'Connor, an estimated $5.6M sold.
Based on aggregated 13F filings for Q4 2022.